Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
T&D Holdings, Inc. (8795.T)
Tokyo, JP
T&D Holdings, Inc., through its subsidiaries, primarily offers a wide range of life insurance products and associated services within Japan. For individual customers, the company provides extensive coverage, including death benefit, medical, and nursing care products, distributed by its in-house sales representatives. Small and medium-sized enterprises (SMEs) can access term life and disability insurance via both internal sales teams and external agents. Additionally, T&D Holdings supplies savings and protection-oriented policies through financial institutions and insurance shops for the independent agent market, alongside specialized pet and family insurance. The company's offerings extend beyond core insurance to include policyholder confirmation, insurance agency services, health and medical research, and comprehensive investment management, advisory, and trust services. It also engages in leasing and credit guarantee services. Furthermore, T&D Holdings provides administrative support for life insurance policies, covering document drafting, amendments, custody, distribution, and securities delivery, as well as developing computer software and system solutions. Founded in 2004, the company's headquarters are located in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.81% | +2.66% | -0.48% | -0.25% | +21.97% | +8.59% | +30.27% | +105.21% | +183.14% | +296.51% | +73.84% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 5 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%-1.1% Q1'26: -39.1% (vs Q1'25)
-
EPS growth Insurance - Life: +13.4%+15.7% ★ Q1'26: +342.7% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Life: +31.7%+10.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Insurance - Life: +12.4%+6.9% Q1'26: +11.0% (vs Q1'25)
-
ROIC Insurance - Life: +1.0%— Q1'26: -178.0% (vs Q1'25)
-
Share dilution Insurance - Life: +0.4%-5.0% ★ Q1'26: -5.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.05× ★ Q1'26: 1.38× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 9 EPS Ana. |
Mar 2027 5 Rev. Ana. 10 EPS Ana. |
Mar 2028 5 Rev. Ana. 8 EPS Ana. |
Mar 2029 1 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.30T
est: 2.27T (+1.2%)
|
1.90T
est: 1.96T (-3.2%)
|
1.80T
est: 1.89T (-4.8%)
|
1.79T
est: 1.91T (-6.3%)
|
1.99T
est: 1.88T (+5.6%)
|
2.02T
est: 1.97T (+2.1%)
|
2.13T
est: 2.10T (+1.5%)
|
2.18T
est: 2.17T (+0.1%)
|
2.51T
est: 2.30T (+9.1%)
|
2.80T
est: 2.68T (+4.5%)
|
2.89T
est: 3.41T (-15.1%)
|
3.24T
2.99T – 3.45T
-5.0% YoY
|
3.26T
2.99T – 3.56T
+0.6% YoY
|
3.26T
2.92T – 3.61T
-0.2% YoY
|
3.38T
3.06T – 3.72T
+3.9% YoY
|
2.86T
2.59T – 3.15T
-15.4% YoY
|
| EBITDA |
150.12B
est: 97.23B (+54.4%)
|
111.15B
est: 84.12B (+32.1%)
|
113.60B
est: 80.90B (+40.4%)
|
126.08B
est: 81.91B (+53.9%)
|
120.93B
est: 80.57B (+50.1%)
|
117.16B
est: 84.51B (+38.6%)
|
159.02B
est: 89.97B (+76.7%)
|
44.82B
est: 92.98B (-51.8%)
|
-81.07B
est: 98.55B (-182.3%)
|
157.54B
est: 465.14B (-66.1%)
|
192.98B
est: 592.63B (-67.4%)
|
563.17B
520.13B – 599.88B
-5.0% YoY
|
566.82B
519.17B – 618.39B
+0.6% YoY
|
565.63B
506.62B – 627.27B
-0.2% YoY
|
587.93B
532.48B – 646.78B
+3.9% YoY
|
497.18B
450.29B – 546.94B
-15.4% YoY
|
| EBIT |
150.12B
est: 74.67B (+101.1%)
|
111.15B
est: 64.60B (+72.0%)
|
97.36B
est: 62.13B (+56.7%)
|
110.29B
est: 62.91B (+75.3%)
|
102.82B
est: 61.88B (+66.2%)
|
98.51B
est: 64.90B (+51.8%)
|
139.18B
est: 69.10B (+101.4%)
|
24.62B
est: 71.40B (-65.5%)
|
-102.25B
est: 75.68B (-235.1%)
|
136.51B
est: 447.10B (-69.5%)
|
171.10B
est: 569.65B (-70.0%)
|
541.33B
499.96B – 576.61B
-5.0% YoY
|
544.84B
499.03B – 594.41B
+0.6% YoY
|
543.69B
486.97B – 602.94B
-0.2% YoY
|
565.13B
511.83B – 621.69B
+3.9% YoY
|
477.90B
432.83B – 525.73B
-15.4% YoY
|
| Net Income |
94.22B
est: 69.05B (+36.4%)
|
72.55B
est: 64.76B (+12.0%)
|
75.19B
est: 66.01B (+13.9%)
|
77.58B
est: 63.65B (+21.9%)
|
72.83B
est: 67.48B (+7.9%)
|
67.10B
est: 55.65B (+20.6%)
|
108.51B
est: 138.79B (-21.8%)
|
14.18B
est: 12.44B (+13.9%)
|
-132.15B
est: -143.62B (+8.0%)
|
98.78B
est: 113.99B (-13.3%)
|
126.41B
est: 129.57B (-2.4%)
|
131.68B
127.20B – 163.66B
+1.6% YoY
|
155.52B
136.34B – 185.66B
+18.1% YoY
|
165.62B
148.78B – 207.46B
+6.5% YoY
|
204.32B
192.37B – 216.28B
+23.4% YoY
|
218.84B
192.01B – 247.31B
+7.1% YoY
|
| SGA |
188.99B
|
188.61B
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
141.35
est: 131.97 (+7.1%)
|
111.00
est: 123.77 (-10.3%)
|
117.81
est: 126.17 (-6.6%)
|
124.23
est: 121.65 (+2.1%)
|
118.50
est: 128.97 (-8.1%)
|
111.31
est: 106.36 (+4.7%)
|
181.54
est: 265.26 (-31.6%)
|
24.39
est: 23.79 (+2.5%)
|
-237.31
est: -274.47 (+13.5%)
|
183.13
est: 213.07 (-14.0%)
|
241.72
est: 241.75 (0.0%)
|
280.93
255.86 – 329.22
+16.2% YoY
|
329.88
274.25 – 373.47
+17.4% YoY
|
358.91
299.29 – 417.32
+8.8% YoY
|
411.00
386.95 – 435.05
+14.5% YoY
|
440.20
386.23 – 497.47
+7.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-01 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-15 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daisuke Sasaki | Chief Accountant | — | — |
| Hotaka Nagai | Head of Finance, Senior Managing Executive Officer & Director | — | male |
| Iwao Kanazawa | Managing Executive Officer | — | — |
| Masahiko Moriyama | President & Representative Director | — | male |
| Satoshi Ito | General Manager of Investor Relations Department | — | male |
| Shuichi Nakamura | Managing Executive Officer | — | male |
| Tomoyasu Isobe | Senior Managing Executive Officer | — | male |
| Toshikatsu Imai | Executive Officer | — | — |
| Yasuhiro Mori | Senior Managing Executive Officer | — | — |
| Yoko Futami | Director and Managing Executive Officer | — | female |
| Yoshitaka Moriya | Managing Executive Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 8795.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
